Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH.

Pediatr Blood Cancer. 2009 Dec;53(6):1016-22. doi: 10.1002/pbc.22088.

2.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall'Igna P, Otte JB, De Camargo B, Zsiros J, Zimmermann A, Aronson D, Childs M, Scopinaro M, Morland B, Plaschkes J, Czauderna P, Perilongo G.

Eur J Cancer. 2012 Jul;48(10):1543-9. doi: 10.1016/j.ejca.2011.12.011. Epub 2012 Jan 13.

PMID:
22244829
3.

Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.

Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, Brown J, Phillips A, Otte JB, Czauderna P, MacKinlay G, Vos A.

J Clin Oncol. 2005 Feb 20;23(6):1245-52.

4.

Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, Finegold MJ.

J Clin Oncol. 2011 Aug 20;29(24):3301-6. doi: 10.1200/JCO.2010.29.3837. Epub 2011 Jul 18.

5.

Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.

Leal-Leal CA, Imaz-Olguín V, Robles-Castro J, Shalkow-Klincovstein J, Palacios-Acosta JM.

Ann Hepatol. 2010 Jan-Mar;9(1):75-9.

PMID:
20308725
6.

[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].

Häberle B, Bode U, von Schweinitz D.

Klin Padiatr. 2003 May-Jun;215(3):159-65. German.

PMID:
12778356
7.

Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.

Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC.

Curr Opin Pediatr. 2014 Feb;26(1):29-36. doi: 10.1097/MOP.0000000000000042. Review.

PMID:
24362406
8.

Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.

Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M; Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.

J Pediatr Surg. 2004 Feb;39(2):195-8; discussion 195-8. Review.

PMID:
14966739
9.

Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.

Davies JQ, de la Hall PM, Kaschula RO, Sinclair-Smith CC, Hartley P, Rode H, Millar AJ.

J Pediatr Surg. 2004 Sep;39(9):1321-7. Review.

PMID:
15359384
10.

Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable?

Zhou S, Gomulia E, Mascarenhas L, Wang L.

Hum Pathol. 2015 Apr;46(4):620-4. doi: 10.1016/j.humpath.2014.12.013. Epub 2015 Jan 14.

PMID:
25649007
11.

Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.

Ismail H, Broniszczak D, Kaliciński P, Dembowska-Bagińska B, Perek D, Teisseyre J, Kluge P, Kościesza A, Lembas A, Markiewicz M.

J Pediatr Surg. 2012 Jul;47(7):1331-9. doi: 10.1016/j.jpedsurg.2011.11.073.

PMID:
22813792
12.

Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.

Koh KN, Park M, Kim BE, Bae KW, Kim KM, Im HJ, Seo JJ.

Pediatr Blood Cancer. 2011 Oct;57(4):554-60. doi: 10.1002/pbc.23069. Epub 2011 Mar 2.

PMID:
21370433
13.

Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.

Meyers RL, Katzenstein HM, Krailo M, McGahren ED 3rd, Malogolowkin MH.

J Pediatr Surg. 2007 Dec;42(12):2050-6.

PMID:
18082706
14.

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, Dicks-Mireaux C, Phillips A, Vos A, Plaschkes J.

Eur J Cancer. 2000 Jul;36(11):1418-25.

PMID:
10899656
15.

The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials.

Aronson DC, Czauderna P, Maibach R, Perilongo G, Morland B.

J Indian Assoc Pediatr Surg. 2014 Oct;19(4):201-7. doi: 10.4103/0971-9261.142001. Review.

16.

Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.

De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, Pritchard J, Shafford L, Zsiros J, Czaudzerna P, Perilongo G.

Eur J Cancer. 2008 Mar;44(4):545-50. doi: 10.1016/j.ejca.2007.11.022. Epub 2007 Dec 31.

PMID:
18166449
17.

Current chemotherapeutic approaches for hepatoblastoma.

Watanabe K.

Int J Clin Oncol. 2013 Dec;18(6):955-61. doi: 10.1007/s10147-013-0616-8. Epub 2013 Sep 20. Review.

PMID:
24052132
18.

Pediatric liver transplantation for hepatoblastoma: a single center experience.

Kim T, Kim DY, Kim KM, Seo JJ, Park KM, Lee YJ, Lee SG.

Transplant Proc. 2012 Mar;44(2):523-5. doi: 10.1016/j.transproceed.2012.01.069.

PMID:
22410061
19.

Survival after liver transplantation for hepatoblastoma: a 2-center experience.

Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.

J Pediatr Surg. 2008 Nov;43(11):1973-81. doi: 10.1016/j.jpedsurg.2008.05.031.

PMID:
18970927
20.

Fetal and neonatal hepatic tumors.

Isaacs H Jr.

J Pediatr Surg. 2007 Nov;42(11):1797-803. Review.

PMID:
18022426
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk